{"title":{"0":"FDA Approves New Treatment for Rare Disease","1":"Major Pharma Company Announces Phase 3 Results"},"source":{"0":"FiercePharma","1":"BioSpace"},"url":{"0":"https:\/\/www.fiercepharma.com\/example","1":"https:\/\/www.biospace.com\/example"},"published_at":{"0":"2026-02-12","1":"2026-02-10"},"summary":{"0":"The FDA has approved a new therapy for a rare genetic disease, marking a significant milestone in treatment options.","1":"A leading pharmaceutical company reported positive Phase 3 trial results for its flagship oncology drug."},"sentiment":{"0":"positive","1":"positive"},"content":{"0":"The FDA has approved a new therapy for a rare genetic disease, marking a significant milestone in treatment options. The drug, developed over a decade, showed promising results in clinical trials.","1":"A leading pharmaceutical company reported positive Phase 3 trial results for its flagship oncology drug. The results exceeded expectations with a 40% improvement in progression-free survival."}}